You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

 

Online download statistics by month:

Online download statistics by month: June 2020 to June 2025

AbstractFullPdf
Jun 2020228228118
Jul 2020979766
Aug 2020585633
Sep 2020575735
Oct 2020505032
Nov 2020383719
Dec 2020424225
Jan 2021535343
Feb 2021555538
Mar 2021535932
Apr 2021333315
May 2021363623
Jun 2021676743
Jul 2021626234
Aug 2021484859
Sep 2021595945
Oct 2021585854
Nov 2021737357
Dec 2021636537
Jan 2022778336
Feb 2022464729
Mar 2022656633
Apr 2022566028
May 2022616635
Jun 2022656521
Jul 2022485025
Aug 2022636336
Sep 2022424466
Oct 2022656731
Nov 2022666829
Dec 2022424218
Jan 2023393915
Feb 2023757724
Mar 2023545526
Apr 2023222318
May 2023242413
Jun 2023272714
Jul 2023484824
Aug 2023272611
Sep 2023232613
Oct 202323236
Nov 202333339
Dec 2023879228
Jan 2024353821
Feb 2024414127
Mar 2024505030
Apr 2024393918
May 2024232316
Jun 2024313122
Jul 2024555692
Aug 2024202013
Sep 2024272773
Oct 2024414134
Nov 2024656636
Dec 2024414128
Jan 2025515435
Feb 2025535329
Mar 2025575739
Apr 2025686925
May 2025565736
Jun 2025545416
Total321532661986